A phase III, randomized, controlled trial on the benefits of adjuvant chemotherapy after resection of oligometastatic foci in patients after primary colorectal cancer radical resection
Ontology highlight
ABSTRACT: Interventions: group with adjuvent chemotherapy:adjuvent chemotherapy;non-adjuvent chemotherapy:Observation and follow-up
Primary outcome(s): 3-year disease-free survival
Study Design: Parallel
DISEASE(S): Colorectal Cancer
PROVIDER: 2696858 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA